JAPANESE PHASE I STUDY OF OLANZAPINE (LY170053): A NEW ANTIPSYCHOTIC DRUGOlanzapine was administered orally to healthy Japanese volunteers (52 subjects) in single dose (0.1 - 6 mg) and multiple dose (1 - 4 mg X 3 days) Phase I studies in order to access tolerance and pharmacokinetics. ...
This study investigated gender differences in the relationship between psychoactive substance use and sexual thoughts, feelings, and behaviors. Participants ( N = 464) were male and female alcohol, opiate, cocaine, and methamphetamine users enrolled in an outpatient treatment program at any of 8 sites...
In controlled clinical studies of acute manic and mixed episodes, olanzapine has proved to be at least as effective as lithium, divalproex, or haloperidol - often with additional benefits, such as faster onset of action, or wider spectrum of target symptoms. Added to mood stabilizers, olanzapine...
5.0 out of 5 stars 1 Paperback 16 offers from $70.99 #45 High-Yield Med Reviews' Top 300 Drugs: Rapid Review & Clinical Pearls (High-Yield Med Reviews' Top Drugs Series) Anthony Busti MD PharmD 4.6 out of 5 stars 7 Paperback 2 offers from $63.00 #46 PTCB EXAM STUDY GUIDE ...
B. et al. The SNAP 101 double-blind, placebo/active-controlled, safety, pharmacokinetic, and pharmacodynamic study of INP105 (nasal olanzapine) in healthy adults. J. Clin. Psychiatry 81, 19m13086 (2020). Google Scholar Van de Bittner, G. C. et al. Positron emission tomography assessment...
An independent review of the pharmacological properties of olanzapine. A page on the pharmacology of Olanzapine an antipsychotic drug
Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication. Therapeutic drug monitoring (TDM) data for the antipsychotic drug olanzapine were investigated with respect to concentration versus dose relationship, intr... M Gex-Fabry,AE Balant-Gorgia,LP Bala...
Drug-induced psychosis is a serious late complication of Parkinson's disease (PD) that requires aggressive treatment. Recent studies have found clozapine a... SA Factor,ES Molho,DL Brown - 《J Neuropsychiatry Clin Neurosci》 被引量: 151发表: 1995年 The Parkinson Study Group. Clozapine for the...
Olanzapine has been recommended as the first-line drug for the treatment of schizophrenia. It is considered an atypical neuroleptic agent with fewer extrapyramidal side effects than classical neuroleptic agents. In the study initially an alternative bioanalytical estimation method, with the added ...
When using olanzapine andfluoxetinein combination, also refer to the boxed warning section of the package insert for Symbyax. Common side effects Common side effects seen with olanzapine are: an inability to sit still (akathisia), constipation, ...